8% Off
Halobet0.05%
Square Pharmaceuticals PLC.
৳119.60
Add to cart
Generic medicine
Halobetasol Propionate: Brands, Price & Uses in Bangladesh
Established / FDA-Approved Uses Halobetasol Propionate cream, ointment, and lotion (0.05%) are indicated for the short-term topical treatment (typically no more than 2 consecutive weeks) of…
About Halobetasol Propionate
Indications of Halobetasol Propionate
Established / FDA-Approved Uses
- Halobetasol Propionate cream, ointment, and lotion (0.05%) are indicated for the short-term topical treatment (typically no more than 2 consecutive weeks) of moderate-to-severe plaque psoriasis in adults, excluding widespread plaque psoriasis, when a super-potent (Class I) topical corticosteroid is warranted.
- Halobetasol Propionate (0.05%) is also indicated for the relief of the inflammatory and pruritic manifestations of other corticosteroid-responsive dermatoses that have not adequately responded to lower-potency corticosteroids, at the discretion of the prescriber.
- A lower-strength lotion formulation of Halobetasol Propionate (0.01%) is approved specifically for plaque psoriasis in adults, reflecting a separate, distinct product strength with its own labeling.
Off-Label / Adjunct Use
- Halobetasol Propionate is sometimes used off-label, under specialist supervision, for other severe corticosteroid-responsive conditions such as lichen planus, discoid lupus erythematosus (localized lesions), and severe hand/foot eczema that has failed lower-potency agents. Such use should be individualized and time-limited.
Halobetasol Propionate is not indicated for widespread plaque psoriasis, and is not a first-line agent for mild dermatoses.
Dosage & Administration of Halobetasol Propionate
Adult Dosage (Plaque Psoriasis and Corticosteroid-Responsive Dermatoses)
| Formulation | Application | Maximum Duration | Maximum Weekly Quantity |
|---|---|---|---|
| Cream / Ointment 0.05% | Apply a thin layer to the affected skin once or twice daily; rub in gently and completely | 2 consecutive weeks | Not to exceed 50 g/week |
| Lotion 0.05% | Apply a thin layer to the affected skin twice daily | 2 consecutive weeks | Not to exceed 50 g (or 50 mL)/week |
| Lotion 0.01% (lower-strength product) | Apply a thin film to the affected skin once daily | Per specific product labeling, generally up to 8 weeks under close supervision | Per specific product labeling |
Treatment should be discontinued when control is achieved. If no improvement is seen within 2 weeks, the diagnosis should be reassessed. The total treated body surface area should not exceed approximately 20% at any time. Halobetasol Propionate should not be used with occlusive dressings unless specifically directed by a physician.
Pediatric Dosage
Safety and efficacy of Halobetasol Propionate 0.05% products have not been established in patients younger than 18 years; use in this age group is not recommended. See Pediatric Uses for further detail.
Renal/Hepatic Impairment
No specific dosage adjustment of topical Halobetasol Propionate is established for renal or hepatic impairment, since systemic exposure from correctly used topical therapy is expected to be low; however, caution and closer monitoring for systemic corticosteroid effects are reasonable if impairment is significant, as clearance of any absorbed drug may be reduced.
Side Effects of Halobetasol Propionate
Common (Local) Side Effects
- Burning, stinging, or itching at the application site
- Skin irritation and dryness
- Folliculitis and acneiform eruptions
- Hypopigmentation
- Perioral dermatitis
- Allergic contact dermatitis
- Miliaria (heat rash)
Less Common but Important Side Effects (usually with excessive/prolonged use)
- Skin atrophy, striae (stretch marks), and telangiectasia (visible small blood vessels), particularly with prolonged use or use on thin-skin areas
- Hypertrichosis (excess hair growth) at the application site
- Secondary infection of treated skin
Systemic Effects (rare, with overuse)
Excessive or prolonged use of Halobetasol Propionate, especially over large areas or under occlusion, can lead to reversible hypothalamic-pituitary-adrenal (HPA)-axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria; these usually resolve upon discontinuation. See Precautions and Warnings.
Contraindications of Halobetasol Propionate
Halobetasol Propionate is contraindicated in patients with known hypersensitivity to Halobetasol Propionate or to any other component of the specific cream, ointment, or lotion formulation being used.
Frequently Asked Questions about Halobetasol Propionate
What is Halobetasol Propionate used for?
Halobetasol Propionate is a super-potent (Class I) topical corticosteroid used for the short-term treatment of moderate-to-severe plaque psoriasis and other corticosteroid-responsive skin conditions that have not responded adequately to weaker steroid creams.
How long can I use Halobetasol Propionate?
Treatment with Halobetasol Propionate should generally not exceed 2 consecutive weeks, and the amount used should not exceed the maximum weekly quantity stated on the product label (commonly 50 g/week for 0.05% products), because of the risk of skin thinning and suppression of your body's own adrenal hormone production with prolonged or excessive use. Always follow your physician's specific instructions.
Can I use Halobetasol Propionate on my face?
No, Halobetasol Propionate should not be applied to the face, groin, armpits, or other skin-fold areas unless your physician has specifically told you to, because these areas have thinner skin that is more prone to steroid-related side effects such as thinning, stretch marks, and visible blood vessels.
Can pregnant or breastfeeding women use Halobetasol Propionate?
Halobetasol Propionate should be used during pregnancy only if the potential benefit clearly justifies the potential risk to the baby, at the lowest effective amount for the shortest time, and only under medical supervision, since there are no adequate controlled studies in pregnant women and topical corticosteroids can be absorbed into the bloodstream. Breastfeeding women should use caution, avoid applying it to the chest/nipple area, and consult a physician before use.
What are the main side effects of Halobetasol Propionate?
Common side effects include burning, stinging, itching, dryness, and irritation at the application site. With prolonged or excessive use, Halobetasol Propionate can cause skin thinning (atrophy), stretch marks, visible blood vessels, and, rarely, suppression of the body's own adrenal (cortisol) production or Cushingoid effects.
Can Halobetasol Propionate be used in children?
Safety and efficacy of Halobetasol Propionate 0.05% products have not been established in patients under 18 years of age, and their use is generally not recommended in this age group because children are more susceptible to systemic side effects from topical steroids. Use in children should only occur under close physician supervision with a specifically labeled product.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.